Primecare Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.00 M
as on 15-11-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 295.54%
(FY 2023)
- Profit 146.84%
(FY 2023)
- Ebitda 33.20%
(FY 2023)
- Net Worth 17.85%
(FY 2023)
- Total Assets 348.59%
(FY 2023)
About Primecare Pharma
The Corporate was formerly known as First Excel Enterprises Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Parveez Ahmed, Mohamed Nayaz, Thummalakuntla Sivudu, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC111171
- Company No.
111171
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Primecare Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohamed Nayaz  | Director | 14-Mar-2018 | Current |
| Parveez Ahmed | Director | 14-Mar-2018 | Current |
| Thummalakuntla Sivudu | Additional Director | 25-Jun-2023 | Current |
| Venkatapathi Bharani | Additional Director | 25-Jun-2023 | Current |
Financial Performance of Primecare Pharma.
Primecare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 295.54% increase. The company also saw a substantial improvement in profitability, with a 146.84% increase in profit. The company's net worth Soared by an impressive increase of 17.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Primecare Pharma?
In 2023, Primecare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Primecare Trading & Consulting LlpActive 4 years 2 monthsParveez Ahmed and Mohamed Nayaz are mutual person
- Primecare Medical Services And Multispeciality Clinics (India) Private LimitedActive 12 years 2 months
Parveez Ahmed and Mohamed Nayaz are mutual person
- Primecare Enterprises Private LimitedActive 6 years 11 months
Parveez Ahmed and Mohamed Nayaz are mutual person
Pharmolife Biotechnologies Private LimitedActive 11 months 14 daysParveez Ahmed and Mohamed Nayaz are mutual person
- Gloaid Pharma Private LimitedActive 9 months 2 days
Parveez Ahmed and Mohamed Nayaz are mutual person
- Coreshelters Infra Private LimitedActive 11 months 25 days
Parveez Ahmed and Mohamed Nayaz are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Primecare Pharma?
Primecare Pharma has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Primecare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primecare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.